+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 75Years
All Genders
ID06443489

Phase 1 Study Evaluating Safety and Effectiveness of SHR-4849 Injection in Adults With Advanced Solid Tumors

Led by Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Updated on 2025-03-05

80

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, and effectiveness of SHR-4849 injections in adults with advanced solid tumors. This phase I, open-label, multicenter clinical trial aims to find a safe and reasonable dose of SHR-4849 for treating these tumors. The study is sponsored by Suzhou Suncadia Biopharmaceuticals Co., Ltd. and focuses on patients aged 18 to 75 years with confirmed advanced solid tumors and measurable lesions. Participants will receive SHR-4849 as the investigational drug during the dose escalation and dose expansion phases. The study observes each participant for dose-limiting toxicities DLTs within 21 days and monitors adverse events for up to 24 months. After dose escalation, the maximum tolerated dose MTD or maximum administered dose MAD and recommended phase 2 dose RP2D will be determined. The trial does not use a placebo or blinding, and the treatment is given under close medical supervision. Throughout the study, participants will undergo regular evaluations including tumor response assessments using RECIST 1.1 criteria, safety monitoring, and pharmacokinetic testing. Researchers will measure outcomes like objective response rate, disease control rate, duration of response, progression-free survival, and overall survival over periods up to 30 months. Safety follow-up extends for 24 months to track adverse events. The total participation time varies depending on the treatment and follow-up schedules.

CONDITIONS

Brief Title

A Trial of SHR-4849 in Advanced Solid Tumors

Research Team

W

wei Hou

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here